Clinical Trials Logo

Finch clinical trials

View clinical trials related to Finch.

Filter by:
  • None
  • Page 1

NCT ID: NCT03829878 Withdrawn - Clinical trials for Autism Spectrum Disorder

Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Autism Spectrum Disorder and Associated GI Symptoms (SPROUT)

SPROUT
Start date: May 2020
Phase: Phase 2
Study type: Interventional

Adolescent autism spectrum disorder subjects with associated GI symptoms will be randomized to receive oral dosing of CP101 capsules in Treatment Group I or matching placebo capsules in Treatment Group II. The purpose of this study is to demonstrate the safety and effectiveness of CP101 in subjects with ASD and associated GI symptoms.